Molecular typing and antifungal susceptibility of clinical isolates of Cryptococcus neoformans and Cryptococcus gattii species complexes from the National Invasive Fungal Surveillance Network of Uruguay

被引:1
|
作者
Puime, Carlos Andres [1 ,3 ]
Bormida, Victoria [1 ]
Pan, Dinorah [2 ]
机构
[1] Minist Salud Publ, Dept Labs Salud Publ, Montevideo 11600, Uruguay
[2] Univ Republica, Fac Ciencias, Fac Ingn, Lab Micol, Montevideo 11300, Uruguay
[3] Inst Higiene Entrada Norte, Dept Labs Salud Publ, Ave Alfredo Navarro 3051, Montevideo 11600, Uruguay
关键词
Cryptococcus neoformans; gattii species complex; molecular typing; AD hybrids; EUCAST; Uruguay; EPIDEMIOLOGY; POPULATION; GENOTYPES; DISTRIBUTIONS; PATTERN; TRENDS;
D O I
10.1093/mmy/myad059
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Cryptococcus neoformans and C. gattii species complexes (phylum: Basidiomycota) are environmental yeasts and are the main cause of human cryptococcosis worldwide. The most recent molecular typing studies in Latin America have focused on the intertropical region. Thus, this study aimed to update the knowledge of human cryptococcosis in the South American temperate region. We obtained and analyzed 116 C. neoformans/C. gattii species complexes isolates from the Public Health Surveillance Laboratory between 2008-2013 and 2017-2021 (C. gattii species complex = 1 and C. neoformans species complex = 115). The average patient age was 45 years, with an overall male:female ratio of 3.1:1. The proportion of HIV-negative patients was significantly higher in the second study period. Restriction fragment length polymorphism typing of URA5 gene revealed that the C. neoformans species complex comprised 75.7% VNI, 2.6% VNII, 0.9% VNIII, 1.7% VNIV, 17.4% VNII/VNIV hybrids, and one C. neoformans isolate (0.9%) misidentified as VGI; the C. gattii species complex isolates comprised one VGII. The overall case fatality rate was 49.5%, with no differences in lethality between VNI and hybrid isolates. Of the four isolates responsible for episodes of reoccurrence, only one had a genotype different from the first episode. Antifungal susceptibility testing revealed that most isolates fell below the local epidemiological cut-off value. This study provides additional information for the analysis of C. neoformans/C. gattii species complexes dynamics in the South American temperate region. Lay Summary This study describes the epidemiological and molecular trends of human cryptococcosis according to the public health Uruguayan surveillance network. The findings provide additional information for analyzing the Cryptococcusneoformans/C. gattii species complexes in the South American temperate region.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages
    Hansakon, Adithap
    Mutthakalin, Putthiphak
    Ngamskulrungroj, Popchai
    Chayakulkeeree, Methee
    Angkasekwinai, Pornpimon
    VIRULENCE, 2019, 10 (01) : 26 - 36
  • [42] Cryptococcus neoformans and Cryptococcus gattii Species Complexes in Latin America: A Map of Molecular Types, Genotypic Diversity, and Antifungal Susceptibility as Reported by the Latin American Cryptococcal Study Group
    Firacative, Carolina
    Meyer, Wieland
    Castaneda, Elizabeth
    JOURNAL OF FUNGI, 2021, 7 (04)
  • [43] Molecular typing of clinical and environmental isolates of Cryptococcus gattii species complex from southern California, United States
    Hurst, Steven
    Lysen, Colleen
    Cooksey, Gail
    Vugia, Duc J.
    Litvintseva, Anastasia P.
    Lockhart, Shawn R.
    MYCOSES, 2019, 62 (11) : 1029 - 1034
  • [44] Molecular typing of clinical Cryptococcus neoformans isolates collected in Germany from 2004 to 2010
    Sanchini, Andrea
    Smith, Ilka McCormick
    Sedlacek, Ludwig
    Schwarz, Roman
    Tintelnot, Kathrin
    Rickerts, Volker
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2014, 203 (05) : 333 - 340
  • [45] Molecular typing of clinical Cryptococcus neoformans isolates collected in Germany from 2004 to 2010
    Andrea Sanchini
    Ilka McCormick Smith
    Ludwig Sedlacek
    Roman Schwarz
    Kathrin Tintelnot
    Volker Rickerts
    Medical Microbiology and Immunology, 2014, 203 : 333 - 340
  • [46] Molecular epidemiology of clinical Cryptococcus gattii isolates from Colombia
    Firacative, C.
    Lizarazo, J.
    Escandon, P.
    Agudelo, C. A.
    Meyer, W.
    Castaneda, E.
    MYCOSES, 2014, 57 : 62 - 63
  • [47] MOLECULAR TYPING OF CRYPTOCOCCUS-NEOFORMANS SEROTYPE-D CLINICAL ISOLATES
    DROMER, F
    VARMA, A
    RONIN, O
    MATHOULIN, S
    DUPONT, B
    JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (10) : 2364 - 2371
  • [48] In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India
    Chowdhary, Anuradha
    Randhawa, Harbans Singh
    Sundar, Gandhi
    Kathuria, Shallu
    Prakash, Anupam
    Khan, Ziauddin
    Sun, Sheng
    Xu, Jianping
    JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 60 (07) : 961 - 967
  • [49] Multilocus sequence typing (MLST) of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in six departments of Colombia reveals high genetic diversity
    Velez, Norida
    Escandon, Patricia
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2020, 53 : 1 - 8
  • [50] Antifungal susceptibility of clinical and environmental isolates of Cryptococcus neoformans to four antifungal drugs determined by two techniques
    Moraes, EMP
    Prímola, NS
    Hamdan, JS
    MYCOSES, 2003, 46 (5-6) : 164 - 168